Drug Profile
Research programme: glycosylated adiponectin - Protemix
Alternative Names: Glycosylated adiponectin; PX 811013Latest Information Update: 27 Jun 2013
Price :
$50
*
At a glance
- Originator Protemix Corporation
- Class
- Mechanism of Action Fatty acid synthetase complex inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alcoholic hepatitis; Non-alcoholic steatohepatitis
Most Recent Events
- 30 Jun 2010 Discontinued - Preclinical for Alcoholic hepatitis in New Zealand (unspecified route)
- 30 Jun 2010 Discontinued - Preclinical for Non-alcoholic steatohepatitis in New Zealand (unspecified route)
- 19 May 2006 Preclinical trials in Alcoholic hepatitis in New Zealand (unspecified route)